Gastrointestinal studies employ chemically induced lesion models (cysteamine, indomethacin, alcohol) in rats, with BPC-157 administered before or after injury
For the survival experiment, mice were checked daily and were culled when they showed visible distress symptoms such as weight loss of 10% or more, ascites equivalent to full-term pregnancy, reduced or slow activity, pale feet, hunching, piloerection, closed eyes and isolation from cage mates
Billing accuracy for each scenario above requires the correct J-code, diagnosis code, and modifier combination
Product Name: BPC-157 Strength:10mg Chemical Name: Body Protection Compound-157 CAS Number: 137525-51-0 Molecular Formula: CHNO Molecular Weight: 1419.56 g/mol Amino Acid Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Appearance: White to Off-White Lyophilized Powder Classification: Synthetic Pentadecapeptide Purity: Verified by analytical testing prior to release Analytical Methods: HPLC, Mass Spectrometry (MS) Research areas commonly associated with this compound include: Tissue Repair Healing & Inflammation Store lyophilized material refrigerated at 28C for routine storage
If irritation rises, or response patterns become less consistent, the problem may not be the peptide alone